Semi-Annual Statement Of Income And Retained Earnings

Astellas Pharma Inc. - Filing #7711337

Concept 2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
72,685,000,000 JPY
-13,490,000,000 JPY
Non-operating income
Non-operating income
141,766,000,000 JPY
303,270,000,000 JPY
Non-operating expenses
Non-operating expenses
4,730,000,000 JPY
4,089,000,000 JPY
Ordinary profit (loss)
209,721,000,000 JPY
285,690,000,000 JPY
Extraordinary income
Extraordinary income
2,297,000,000 JPY
8,476,000,000 JPY
Extraordinary losses
Extraordinary losses
16,286,000,000 JPY
2,594,000,000 JPY
Profit (loss) before income taxes
195,733,000,000 JPY
291,573,000,000 JPY
Income taxes - current
11,474,000,000 JPY
16,035,000,000 JPY
Income taxes - deferred
5,579,000,000 JPY
-21,281,000,000 JPY
Profit (loss)
178,679,000,000 JPY
JPY
JPY
178,679,000,000 JPY
JPY
JPY
JPY
JPY
178,679,000,000 JPY
JPY
JPY
JPY
178,679,000,000 JPY
JPY
JPY
JPY
296,818,000,000 JPY
JPY
JPY
JPY
JPY
JPY
296,818,000,000 JPY
JPY
296,818,000,000 JPY
JPY
296,818,000,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.